As a prevalent neurodevelopmental disease, attention-deficit hyperactivity disorder (ADHD) impairs the learning and memory capacity, and so far, there has been no available treatment option for long-term efficacy. Alterations in gene regulation and synapse-related proteins influence learning and memory capacity; nevertheless, the regulatory mechanism of synapse-related protein synthesis is still unclear in ADHD. LncRNAs have been found participating in regulating genes in multiple disorders. For instance, lncRNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) has an essential regulatory function in numerous psychiatric diseases. However, how MALAT1 influences synapse-related protein synthesis in ADHD remains largely unknown. Here, our study found that MALAT1 decreased in the hippocampus tissue of spontaneously hypertensive rats (SHRs) compared to the standard controls, Wistar Kyoto (WKY) rats. Subsequent experiments revealed that MALAT1 enhanced the expression of neurexin 1 (NRXN1), which promoted the synapse-related genes (SYN1, PSD95, and GAP43) expression. Then, the bioinformatic analyses predicted that miR-141-3p and miR-200a-3p, microRNAs belonging to miR-200 family and sharing same seed sequence, could interact with MALAT1 and NRXN1 mRNA, which were further confirmed by luciferase report assays. Finally, rescue experiments indicated that MALAT1 influenced the expression of NRXN1 by sponging miR-141-3p/200a-3p. All data verified our hypothesis that MALAT1 regulated synapse-related proteins (SYN1, PSD95, and GAP43) through the MALAT1-miR-141-3p/200a-3p-NRXN1 axis in ADHD. Our research underscored a novel role of MALAT1 in the pathogenesis of impaired learning and memory capacity in ADHD and may shed more light on developing diagnostic biomarkers and more effective therapeutic interventions for individuals with ADHD.

The 1st Clinical Medical College of Nanjing Medical University Nanjing Jiangsu China; Department of Children's Health Care The 1st Affiliated Hospital of Nanjing Medical University Jiangsu Maternal and Child Health Care Hospital Nanjing Jiangsu China

See more in PubMed

Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet. 2020;395:450–462. doi: 10.1016/S0140-6736(19)33004-1. PubMed DOI PMC

Hontelez S, Stobernack T, Pelsser LM, van Baarlen P, Frankena K, Groefsema MM, Kleerebezem M, et al. Correlation between brain function and ADHD symptom changes in children with ADHD following a few-foods diet: an open-label intervention trial. Sci Rep. 2021;11:22205. doi: 10.1038/s41598-021-01684-7. PubMed DOI PMC

Marquez-Caraveo ME, Rodriguez-Valentin R, Perez-Barron V, Vazquez-Salas RA, Sanchez-Ferrer JC, De Castro F, Allen-Leigh B, et al. Children and adolescents with neurodevelopmental disorders show cognitive heterogeneity and require a person-centered approach. Sci Rep. 2021;11:18463. doi: 10.1038/s41598-021-97551-6. PubMed DOI PMC

Chang Z, Ghirardi L, Quinn PD, Asherson P, D’Onofrio BM, Larsson H. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biol Psychiatry. 2019;86:335–343. doi: 10.1016/j.biopsych.2019.04.009. PubMed DOI PMC

Michetti C, Falace A, Benfenati F, Fassio A. Synaptic genes and neurodevelopmental disorders: From molecular mechanisms to developmental strategies of behavioral testing. Neurobiol Dis. 2022;173:105856. doi: 10.1016/j.nbd.2022.105856. PubMed DOI

Goto A, Bota A, Miya K, Wang J, Tsukamoto S, Jiang X, Hirai D, et al. Stepwise synaptic plasticity events drive the early phase of memory consolidation. Science. 2021;374:857–863. doi: 10.1126/science.abj9195. PubMed DOI

Feng X, Zhan F, Luo D, Hu J, Wei G, Hua F, Xu G. LncRNA 4344 promotes NLRP3-related neuroinflammation and cognitive impairment by targeting miR-138-5p. Brain Behav Immun. 2021;98:283–298. doi: 10.1016/j.bbi.2021.08.230. PubMed DOI

Uthman YA, Ibrahim KG, Abubakar B, Bello MB, Malami I, Imam MU, Qusty N, et al. MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer. Biochem Pharmacol. 2021;190:114657. doi: 10.1016/j.bcp.2021.114657. PubMed DOI

Li L, Xu Y, Zhao M, Gao Z. Neuro-protective roles of long non-coding RNA MALAT1 in Alzheimer’s disease with the involvement of the microRNA-30b/CNR1 network and the following PI3K/AKT activation. Exp Mol Pathol. 2020;117:104545. doi: 10.1016/j.yexmp.2020.104545. PubMed DOI

Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–D97. doi: 10.1093/nar/gkt1248. PubMed DOI PMC

Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48:W244–W251. doi: 10.1093/nar/gkaa467. PubMed DOI PMC

McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, Bartel DP. The biochemical basis of microRNA targeting efficacy. Science. 2019;366:eaav1741. doi: 10.1126/science.aav1741. PubMed DOI PMC

Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127–D131. doi: 10.1093/nar/gkz757. PubMed DOI PMC

Zhang S, Wu D, Xu Q, You L, Zhu J, Wang J, Liu Z, et al. The protective effect and potential mechanism of NRXN1 on learning and memory in ADHD rat models. Exp Neurol. 2021;344:113806. doi: 10.1016/j.expneurol.2021.113806. PubMed DOI

Wang H, Zheng X, Jin J, Zheng L, Guan T, Huo Y, Xie S, et al. LncRNA MALAT1 silencing protects against cerebral ischemia-reperfusion injury through miR-145 to regulate AQP4. J Biomed Sci. 2020;27:40. doi: 10.1186/s12929-020-00635-0. PubMed DOI PMC

Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006;34:W451–W454. doi: 10.1093/nar/gkl243. PubMed DOI PMC

Mechler K, Banaschewski T, Hohmann S, Hage A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. 2022;230:107940. doi: 10.1016/j.pharmthera.2021.107940. PubMed DOI

Qi S, Schumann G, Bustillo J, Turner JA, Jiang R, Zhi D, Fu Z, et al. Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker. Biol Psychiatry. 2021;90:529–539. doi: 10.1016/j.biopsych.2021.01.011. PubMed DOI PMC

Kozłowska A, Wojtacha P, Równiak M, Kolenkiewicz M, Tsai ML. Differences in serum steroid hormones concentrations in Spontaneously Hypertensive Rats (SHR) - an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD) Physiol Res. 2019;68:25–36. doi: 10.33549/physiolres.933907. PubMed DOI

Honore E, Khlaifia A, Bosson A, Lacaille JC. Hippocampal Somatostatin Interneurons, Long-Term Synaptic Plasticity and Memory. Front Neural Circuits. 2021;15:687558. doi: 10.3389/fncir.2021.687558. PubMed DOI PMC

Messa M, Congia S, Defranchi E, Valtorta F, Fassio A, Onofri F, Benfenati F. Tyrosine phosphorylation of synapsin I by Src regulates synaptic-vesicle trafficking. J Cell Sci. 2010;123:2256–2265. doi: 10.1242/jcs.068445. PubMed DOI

Corradi A, Zanardi A, Giacomini C, Onofri F, Valtorta F, Zoli M, Benfenati F. Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment. J Cell Sci. 2008;121:3042–3051. doi: 10.1242/jcs.035063. PubMed DOI

Jung S, Park M. Shank postsynaptic scaffolding proteins in autism spectrum disorder: Mouse models and their dysfunctions in behaviors, synapses, and molecules. Pharmacol Res. 2022;182:106340. doi: 10.1016/j.phrs.2022.106340. PubMed DOI

Rekart JL, Meiri K, Routtenberg A. Hippocampal-dependent memory is impaired in heterozygous GAP-43 knockout mice. Hippocampus. 2005;15:1–7. doi: 10.1002/hipo.20045. PubMed DOI

Ross PJ, Zhang WB, Mok RSF, Zaslavsky K, Deneault E, D’Abate L, Rodrigues DC, et al. Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS. Biol Psychiatry. 2020;87:139–149. doi: 10.1016/j.biopsych.2019.07.014. PubMed DOI PMC

Lee TS, Li AY, Rapuano A, Mantis J, Eid T, Seyfried TN, de Lanerolle NC. Gene expression in the epileptic (EL) mouse hippocampus. Neurobiol Dis. 2021;147:105152. doi: 10.1016/j.nbd.2020.105152. PubMed DOI

Ushkaryov YA, Petrenko AG, Geppert M, Sudhof TC. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science. 1992;257:50–56. doi: 10.1126/science.1621094. PubMed DOI

Gomez AM, Traunmuller L, Scheiffele P. Neurexins: molecular codes for shaping neuronal synapses. Nat Rev Neurosci. 2021;22:137–151. doi: 10.1038/s41583-020-00415-7. PubMed DOI PMC

Fuccillo MV, Pak C. Copy number variants in neurexin genes: phenotypes and mechanisms. Curr Opin Genet Dev. 2021;68:64–70. doi: 10.1016/j.gde.2021.02.010. PubMed DOI PMC

Avazzadeh S, McDonagh K, Reilly J, Wang Y, Boomkamp SD, McInerney V, Krawczyk J, et al. Increased Ca(2+) signaling in NRXN1alpha (+/−) neurons derived from ASD induced pluripotent stem cells. Mol Autism. 2019;10:52. doi: 10.1186/s13229-019-0303-3. PubMed DOI PMC

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358. doi: 10.1016/j.cell.2011.07.014. PubMed DOI PMC

Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14:dmm047662. doi: 10.1242/dmm.047662. PubMed DOI PMC

Gong D, Zhao ZW, Zhang Q, Yu XH, Wang G, Zou J, Zheng XL, et al. The Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript-1 Regulates CCDC80 Expression by Targeting miR-141-3p/miR-200a-3p in Vascular Smooth Muscle Cells. J Cardiovasc Pharmacol. 2020;75:336–343. doi: 10.1097/FJC.0000000000000798. PubMed DOI

Bahmani L, Baghi M, Peymani M, Javeri A, Ghaedi K. MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expression. Hum Cell. 2021;34:1375–1387. doi: 10.1007/s13577-021-00558-4. PubMed DOI

Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008;22:894–907. doi: 10.1101/gad.1640608. PubMed DOI PMC